Video

Face- Phase-Off: Matching CDMO Capabilities To Your mRNA-LNP Development Stage

Source: Advancing RNA

There are many different criteria for selecting a CDMO for your mRNA products. (FYI this is a topic the panel delves into more deeply in another clip!) But as Arcturus’ Qian Ruan prefaces here, a product’s stage of development and the specific needs inherent to that phase of development should be an important guide for companies today, especially given the expansion of the outsourcing sector and the wide range of capabilities within the sector. 

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)